Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A recommended scale for cognitive screening in clinical trials of Parkinson's disease.
Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group. Chou KL, et al. Among authors: gitelman d. Mov Disord. 2010 Nov 15;25(15):2501-7. doi: 10.1002/mds.23362. Mov Disord. 2010. PMID: 20878991 Free PMC article.
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K. Schuff N, et al. Among authors: gitelman dr. Mov Disord. 2015 Dec;30(14):1885-92. doi: 10.1002/mds.26325. Epub 2015 Aug 11. Mov Disord. 2015. PMID: 26260437
Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup.
Daffner KR, Gale SA, Barrett AM, Boeve BF, Chatterjee A, Coslett HB, D'Esposito M, Finney GR, Gitelman DR, Hart JJ Jr, Lerner AJ, Meador KJ, Pietras AC, Voeller KS, Kaufer DI. Daffner KR, et al. Among authors: d esposito m, gitelman dr. Neurology. 2015 Sep 8;85(10):910-8. doi: 10.1212/WNL.0000000000001763. Epub 2015 Jul 10. Neurology. 2015. PMID: 26163433 Free PMC article.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Effects of donepezil on cognitive functioning in Down syndrome.
Johnson N, Fahey C, Chicoine B, Chong G, Gitelman D. Johnson N, et al. Among authors: gitelman d. Am J Ment Retard. 2003 Nov;108(6):367-72. doi: 10.1352/0895-8017(2003)108<367:EODOCF>2.0.CO;2. Am J Ment Retard. 2003. PMID: 14561111 Clinical Trial.
125 results